financetom
Business
financetom
/
Business
/
Altus Power Starts Strategic Review, Hires Advisors
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Altus Power Starts Strategic Review, Hires Advisors
Oct 17, 2024 1:05 PM

05:10 PM EDT, 10/15/2024 (MT Newswires) -- Altus Power ( AMPS ) jumped 3% in extended session late Tuesday after saying its board members have been conducting a review of strategic alternatives in a bid to unlock shareholder value and optimize its access to capital.

Moelis, and Latham & Watkins have been retained as financial and legal advisors, the company said, adding it expects to complete the review during H1 2025.

Altus cautioned there was no assurance the current review will result in a particular transaction and will make further statements when additional disclosure is needed or appropriate.

It also reaffirmed previously disclosed financial forecast of $196 million to $201 million in revenue for its fiscal 2024 ending in December.

Price: 3.1100, Change: +0.09, Percent Change: +2.98

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
POET Technologies Plans a $25 Million Non-Brokered Public Offering of Units
POET Technologies Plans a $25 Million Non-Brokered Public Offering of Units
Dec 12, 2024
08:47 AM EST, 12/12/2024 (MT Newswires) -- POET Technologies ( POET ) said Thursday that it plans to complete a non-brokered public offering of 5 million units at $5 per unit for a total gross proceeds of $25 million. The company said each unit has one share and one-half of a common share purchase warrant, with each full warrant being...
Knight Therapeutics Says Tavalisse Approved in Mexico
Knight Therapeutics Says Tavalisse Approved in Mexico
Dec 12, 2024
08:44 AM EST, 12/12/2024 (MT Newswires) -- Knight Therapeutics ( KHTRF ) on Thursday said that its Mexican affiliate received regulatory approval for Tavalisse, for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. Thrombocytopenia is a platelet disorder where the platelet count is too low. Tavalisse,...
Warner Bros Discovery to restructure, split TV and streaming businesses into two units
Warner Bros Discovery to restructure, split TV and streaming businesses into two units
Dec 12, 2024
(Reuters) - Warner Bros Discovery ( WBD ) said on Thursday it would implement a new corporate structure where it would serve as the parent for two distinct operating divisions - linear TV business and a unit comprising its studios and streaming platform. ...
Vraylar sales growth seen slowing in 2025, says Richter CEO
Vraylar sales growth seen slowing in 2025, says Richter CEO
Dec 12, 2024
* Richter's CEO expects slower growth in Vraylar sales * Core business revenue growth surpasses Vraylar, CEO says * Richter faces challenges in Russian operations due to sanctions By Anita Komuves BUDAPEST, Dec 12 (Reuters) - Hungarian pharmaceutical company Richter expects a slowdown in sales growth for its flagship product, Vraylar, next year while supply chain disruptions continue to pose...
Copyright 2023-2026 - www.financetom.com All Rights Reserved